News
Alexandre Templier will speak at the Real-World Ev...
Quinten Health will be at the Real-World Evidence and Market Access Conference in Frankfurt, Germany.Alexandre Templier (President)will attend as...
Quinten Health at BiotechX Europe 2023 for the sec...
Quinten Health will be at BioTechX Europe in Basel, Switzerland.For the second year running, Quinten Health will be present at BioTechX! It's an...
Unicancer and Quinten Health partner to develop a ...
Clinical trials in oncology can now be de-risked and their results projected into long term real-world outcomes by combining Unicancer's clinical...
Quinten Health Makes its entrance at ERS Internati...
Quinten Health will be at ERS International Congress 2023 in Milan on September 9-13!Don't miss our first appearance at ERS International...
Machine learning algorithm identifies undiagnosed ...
Experts at Quinten Health have developed a supervised machine learning algorithm to identify undiagnosed episodes of pertussis in adolescents and...
Developing a machine learning algorithm to detect ...
Quinten Health has developed a machine learning algorithm to identify misdiagnosed or undiagnosed episodes of whooping cough in patients...
Quinten Health’s poster selected for presentatio...
Quinten Health's team presented their poster “Artificial intelligence for real-life disease modeling: vision, examples and impact on drug...
AliBERT : the first pretrained language model for ...
The paper “AliBERT : A pretrained language model for French biomedical text” was written in collaboration with Aman Berhe, Guillaume Draznieks,...
Quinten Health receives the Top 5% Poster...
Quinten Health is proud to announce that it has received the "Top 5% Poster" award at the 2023 ISPOR conference ! This distinction was awarded to...
Real-World Data analysis on Fabry’s disease prov...
The article “Cluster analysis of kidney function decline among males with Fabry disease in a large United States electronic health records...
Identifiying predictive factors of diabetic ketoac...
The article “Identification of Predictive Factors of Diabetic Ketoacidosis in Type 1 Diabetes Using a Subgroup Discovery Algorithm” was written...
ISPOR Annual 2023
Quinten Health will be at ISPOR Annual 2023 in Boston!On May 7-10, Quinten Health will be at the at ISPOR 2023 in Boston ! We will present 3...
“Securing & accelerating clinical developme...
Alexandre Templier, President of Quinten Health, was invited last Thursday by Norbert Nabet (Ziwig Biotech) to take part in a round table...
Horizon Europe: Quinten Health into More-EUROPA...
Quinten Health is participating in the More-EUROPA project in the framework of the Horizon Europe program. The latter funds projects aiming to...
Join us at the Live Spotlight Session at DIA Europ...
Quinten Health will speak at DIA Europe 2023 at the Congress Center Basel, Switzerland.Quinten Health will animate a Live Session about "Faster...
Quinten Health innovates at DIA Basel 2023 with Re...
We are thrilled to announce that March 23rd, Quinten Health will animate a 𝗟𝗶𝘃𝗲 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 at 𝗗𝗜𝗔 𝗘𝘂𝗿𝗼𝗽𝗲 𝟮𝟬𝟮𝟯.Billy Amzal, CEO of Quinten Health and...
Don’t miss us at DIA Europe 2023!
Quinten Health will be at the DIA Europe 2023 at the Congress Center Basel in Switzerland.From 22 March to 24 March, 2023 we will be at DIA...
Our new clustering method “Qluster” is out!
Discover our new article "Qluster" referring to a generic and robust method of clustering health data. Already applied on many projects, this...
Discover our new work around patients’ perce...
The poster "𝘼 𝙉𝙖𝙩𝙪𝙧𝙖𝙡 𝙇𝙖𝙣𝙜𝙪𝙖𝙜𝙚 𝙋𝙧𝙤𝙘𝙚𝙨𝙨𝙞𝙣𝙜 (#𝙉𝙇𝙋) 𝘼𝙥𝙥𝙧𝙤𝙖𝙘𝙝 𝙩𝙤 𝘼𝙪𝙩𝙤𝙢𝙖𝙩𝙚 𝙋𝙖𝙩𝙞𝙚𝙣𝙩𝙨’ 𝙏𝙚𝙨𝙩𝙞𝙢𝙤𝙣𝙞𝙖𝙡𝙨 𝘼𝙣𝙖𝙡𝙮𝙨𝙞𝙨" was written in collaboration with Mélissa...
Our team will present a poster at Journées de Bio...
Quinten Health will be at the Journées de Biostatiques 2022 in Rennes, at the INSA School.Mélissa Rollot (Manager Data Scientist) and Coriande...
We will speak at BiotechX 2022
Quinten Health will be at the Biotech X 22 at Basel Congress Center, Switzerland.Alexandre Templier (President and co-founder) and Frank Ahrens...